Literature DB >> 3481245

Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.

M Sachdeva1, C Hackbarth, F B Stella, H F Chambers.   

Abstract

The activity of CGP 31608 for 53 strains of Staphylococcus aureus and 48 strains of S. epidermidis, both methicillin susceptible and resistant, was compared with that of vancomycin, nafcillin, cefamandole, and imipenem. Microdilution MICs were determined in Mueller-Hinton broth with or without 2.5% NaCl at an inoculum of 3 x 10(5) CFU/ml with a 20-h, 37 degrees C incubation. The MICs of imipenem and CGP 31608 for methicillin-resistant strains were lower than the MICs of nafcillin or cefamandole for these strains; these differences diminished in the presence of 2.5% NaCl. Subpopulations were detected in strains of methicillin-resistant S. aureus and S. epidermidis that were resistant to all the beta-lactam antibiotics tested at 5 micrograms/ml. This resistant subpopulation produced progeny that were uniformly resistant to high concentrations of each of the beta-lactams.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3481245      PMCID: PMC174987          DOI: 10.1128/AAC.31.10.1549

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.

Authors:  C J Shanholtzer; L R Peterson; M L Mohn; J A Moody; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

2.  In vitro activity of CGP 31608, a new penem.

Authors:  R Wise; J M Andrews; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.

Authors:  R F Frongillo; P Bianchi; A Moretti; M B Pasticci; S Ripa; S Pauluzzi
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

4.  Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.

Authors:  H F Chambers; C J Hackbarth; T A Drake; M G Rusnak; M A Sande
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

5.  In vitro activity and beta-lactamase stability of a new penem, CGP 31608.

Authors:  H C Neu; N X Chin; N M Neu
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.

Authors:  G J Vazquez; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

  6 in total
  5 in total

1.  Failure of routine susceptibility tests to detect imipenem resistance among strains of methicillin-resistant Staphylococcus aureus.

Authors:  J M Boyce; E Papa; R Dickenson; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Authors:  Jennifer Dien Bard; Janet A Hindler; Howard S Gold; Brandi Limbago
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

Review 3.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production.

Authors:  M Venditti; C Santini; P Serra; A Micozzi; G Gentile; P Martino
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 5.  Methicillin-resistant staphylococci.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.